The inhibitory effect of ISO on YY1-mediated EMT combined with anti-PD-L1 antibody may reprogram the tumor immune microenvironment and enhance the antitumor effect of tumor immunocheckpoint inhibitors. Here, CD274 is linked to neoplasm.